FNKCX | VMVAX | FNKCX / VMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 14 years | 13 years | - |
Gain YTD | 20.706 | 14.833 | 140% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1500 | 3000 | 50% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 23.1M | 32.8B | 0% |
Annual Yield % from dividends | 1.78 | 2.14 | 83% |
Returns for 1 year | 15.36 | 15.41 | 100% |
Returns for 3 years | 19.64 | 14.48 | 136% |
Returns for 5 years | 40.27 | 40.94 | 98% |
Returns for 10 years | 7.20 | 89.30 | 8% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GCSVX | 11.08 | N/A | N/A |
Geneva SMID Cap Growth Institutional | |||
ICEUX | 38.75 | -0.07 | -0.18% |
NYLI Epoch International Choice Class I | |||
NREAX | 14.35 | -0.05 | -0.37% |
Neuberger Berman Real Estate A | |||
CEMVX | 11.62 | -0.06 | -0.51% |
Causeway Emerging Markets Investor | |||
FGIKX | 64.15 | -0.44 | -0.68% |
Fidelity Growth & Income K |